Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded on March 30, 2007 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Alpine Immune Sciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alpine Immune Sciences Inc market cap is $4.46B.
What is the 52-week high for Alpine Immune Sciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alpine Immune Sciences Inc 52 week high is $65.00 as of September 17, 2025.
What is the 52-week low for Alpine Immune Sciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alpine Immune Sciences Inc 52 week low is $8.33 as of September 17, 2025.
What is Alpine Immune Sciences Inc stock price today?
Alpine Immune Sciences Inc stock price today is $64.97.
What was Alpine Immune Sciences Inc stock price yesterday?
Alpine Immune Sciences Inc stock price yesterday was $64.96.
What is the PE ratio of Alpine Immune Sciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alpine Immune Sciences Inc’s P/E ratio is -93.75.
What is the Price-to-Book ratio of Alpine Immune Sciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alpine Immune Sciences Inc P/B ratio is 12.8010.
What is the 50-day moving average of Alpine Immune Sciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alpine Immune Sciences Inc 50-day moving average is $56.54.
